Inventor · disambiguated record
Marcel Gubler
Also filed as: GUBLER MARCEL
5 granted patents·4 pending applications·2 citations·filing 2002–2022
64Inventor score
Top patents by PatentIndex Score
9 records- 0174US11105794B2In vitro nephrotoxicity screening assayHOFFMANN LA ROCHE·Filed 2017·Granted Aug 31, 2021·1 cites·21 claims
- 0263US2023304089A1In vitro nephrotoxicity screening assayHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0362US2021405027A1In vitro nephrotoxicity screening assayHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0461US7459480B2Benzodioxepine derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Dec 2, 2008·1 cites·10 claims
- 0554US11479818B2In vitro nephrotoxicity screening assayHOFFMANN LA ROCHE·Filed 2017·Granted Oct 25, 2022·0 cites·23 claims
- 0644US7868030B2FBPase inhibitors for diabetesHOFFMANN LA ROCHE·Filed 2007·Granted Jan 11, 2011·0 cites·19 claims
- 0741US10815481B2Chiral library screenROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Granted Oct 27, 2020·0 cites·14 claims
- 0841US2017008949A1Use of the binding domain of a subunit of a multi-subunit structure for targeted delivery of pharmaceutically active entities to the multi-subunit structureHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 0934US2003144345A1Treatment of metabolic diseases with soraphen derivativesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcel Gubler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →